They began a series of studies looking at the many
peripheral effects of opioids and the potential benefits of blocking those effects.
Not exact matches
A study in rats published August 25 in Cell Reports suggests that a different approach that targets delta
opioid receptors on sensory neurons in
peripheral tissues might avoid the side
effects and high abuse potential
of currently available pain relievers.
Moreover, rats with reduced GRK2 levels in
peripheral sensory neurons regained sensitivity to the pain - relieving
effects of a drug that activates delta
opioid receptors without the need for an inflammatory trigger.
«Being able to increase the responsiveness
of peripheral opioid receptor systems could lead to a reduction in systemic
opioid administration, thereby reducing the incidence
of side
effects.»
This drug, marketed as Relistor ™, was designed to block the
peripheral side
effects of opioids, such as nausea and constipation, without disrupting pain relief, which occurs in the brain.